NEW YORK (GenomeWeb News) – Helicos BioSciences today said that it has signed a definitive agreement with certain investors to raise gross proceeds of around $18.6 million through a private placement of the firm’s shares.
 
The Cambridge, Mass.-based sequencing technology firm said that net proceeds from the offering will be roughly $17.9 million, which it intends to use for working capital and general corporate purposes.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.